Aims-To clarify the relation between the serum titre of anti-Helicobacter pylon (H pylon) 
Helicobacter pylori, first isolated by Warren and Marshall in 1983, has been implicated in the pathogenesis of peptic ulcer." Its relation to gastric cancer has been also noted recently, particularly in patients with intestinal-type carcinoma with underlying intestinal metaplasia.t Conversely, Hpylori has been reported to occur infrequently in areas of intestinal metaplasia.5-Until recently, the techniques available for the detection of H pylon (isolation-culture, assessment of urease activity, and microscopic examination after Gram staining)'0 all required biopsy specimens of the gastric mucosa. The problem with all these techniques is that they yield no information about infection in any part of the gastric mucosa other than the site of biopsy. The The biopsy specimens were routinely processed and stained with haematoxylin and eosin. The presence or absence of intestinal metaplasia was determined by a single pathologist throughout the study.
The extent of histological changes was assessed from the biopsies taken from the five different sites previously described, and was assigned to groups showing absent, moderate, or extensive intestinal metaplasia.
As metaplastic changes appear first at the antrum or angulus of the stomach and extend towards the upper body,20 subjects who showed metaplasia in the upper gastric body were defined as the group with extensive intestinal metaplasia. Subjects without metaplasia showed no metaplastic changes in any biopsy specimens. The group with moderate intestinal metaplasia included subjects in whom changes were detected in one or more specimens from the antrum, angulus, lower body and/or middle body, but not in the upper body.
We also allocated subjects to two subgroups according to their serum PGI concentrations: a low PGI group (PGI < 30 ng/ml) with severe atrophic gastritis,'"'9 and a normal PGI group (PGI >30 ng/ml) with absent or lesser degrees of atrophic gastritis, irrespective of the extent of intestinal metaplasia. The Wilcoxon rank sum test was used to compare the titre of anti-Hpyloni antibody between the groups with intestinal metaplasia (extensive or moderate) and the group without changes. The Bonferroni correction with ttest was used to compare the PGI levels among the three groups. Probability (p) values less than 0-05 were considered to indicate a significant difference.
Results

ANTI-H PYLORI IgG TITRE AND INTESTINAL
METAPLASIA
Eighty three ofthe 95 subjects (87%) examined had positive antibodies to H pylori. The prevalence of H pylori positivity was uniformly high in all groups irrespective of the extent of intestinal metaplasia (table 1) . Subjects who were anti-H pylori IgG negative were excluded from further analysis since they were considered not to have any history of H pylon infection. Among the 83 seropositive subjects, 24 had no intestinal metaplasia according to our classification, 21 had moderate intestinal metaplasia, and 38 extensive intestinal metaplasia. The percentage of seropositive patients in these groups was similar (92%, 91%, and 83% respectively). However, there was a negative association between the extent of metaplasia and the anti-Hpyloni titre. The prevalence of a high (3 +) titre of anti-H pylori antibody was 75% in the group without metaplasia, 43% in the group with moderate metaplasia, and 37% in the group with extensive metaplasia. The difference was statistically significant between the group without metaplasia and the group with extensive metaplasia (p = 0 007, table 2).
ANTI-H PYLORI IgG TITRE AND GASTRIC ATROPHY Table 3 shows the proportions of subjects with low (1 +), medium (2 +), and high (3 +) titres 
